http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4399147-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-937 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-937 |
| filingDate | 1978-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34628049256aaab225a219993e040d6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fedf88b663bc51b1d1e30b524fd8b47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29ff8d9e0323ce65a3749eacb09b4e6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c30f1dd522a09387a886b20c2c96edd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eeae1b777201c1ca98d195cb4e84ad1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_156db00e2d809bd00983d9dfed3f70f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59b72f1da74dc80480bf5c440b9dc994 |
| publicationDate | 1983-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4399147-A |
| titleOfInvention | Prostaglandin 12 analogues and their pharmaceutical compositions |
| abstract | Prostaglandin I 2 analogues of the formula: ##STR1## [wherein X represents trans-vinylene or an ethylene group unsubstituted or substituted by a bromine atom at the C-5 position, Y represents trans-vinylene or ethylene, R 1 represents hydrogen or an alkyl group containing from 1 to 12 carbon atoms, R 2 represents hydrogen or methyl or ethyl, R 3 represents a single bond or an alkylene group containing from 1 to 4 carbon atoms, R 4 represents hydrogen, an alkyl group containing from 1 to 8 carbon atoms, a cycloalkyl group containing from 4 to 7 carbon atoms unsubstituted or substituted by at least one alkyl group containing from 1 to 8 carbon atoms, or a phenyl or phenoxy group unsubstituted or carrying at least one substituent selected from halogen atoms, the trifluoromethyl group and alkyl groups containing from 1 to 3 carbon atoms, and the wavy line attached to the carbon atoms in positions 6, 11 and 15 depicted in the formula represents α- or β-configuration or mixtures thereof] are new compounds possessing pharmacological properties typical of prostaglandins, for example PGI 2 , and are more stable than PGI 2 . |
| priorityDate | 1977-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 576.